The contact with stinging nettles is very unpleasant. Immediately, a red and itchy skin rash occurs. From a medical point of view, this is a form of urticaria. At any moment, up to 1% of the population suffers from urticaria without even getting in touch with stinging nettles. The wheals and the intolerable itching appear out of the blue and in many cases daily over months or years. It does not take much imagination to understand how excruciating this disease really is.
The diagnosis and treatment of urticaria is a big challenge for patients and doctors, since the disease has a great variety of triggers and reasons. The cause of the disease can be identified for max. 70% of the patients after a complex series of tests. Even if doctors succeed in identifying the cause, a curative therapy is only possible for some patients, e.g. with an antibiotic treatment. All remaining cases require a symptomatic therapy. Although there are effective and well tolerated treatment methods by now, many patients still receive insufficient therapies or therapies with a lot of side effects as for example a long-term treatment with cortisone.
In order to focus more on patients who suffer from urticaria and to raise awareness for the disease and the best possible treatment, the urtikaria network – UNEV and DAAB – Deutscher Allergie- und Asthmabund (German Allergy and Asthma Association) initiate the third urticariaday worldwide on 1st October 2016.
There will be worldwide events for doctors and patients on the topic urticaria. Patients who suffer from urticaria, self-help groups, health-care professionals and everyone, who wants to participate can get information on the website www.urticariaday.org.
You can receive further information (such as interviews with experts or people affected, more detailed texts or advice for everyday life) from our press offices:
The DAAB was founded in 1897 and is located in Mönchengladbach. It is the largest and oldest patient organization in the field of allergies, asthma and neurodermitis. There are currently 18,000 members. The main tasks include the care for people suffering from allergy or asthma, consumer protection from dubious allergology offers, press and public relations, lobbying and liaison between different occupational groups in the field of allergology (networking). The DAAB is an independent non-profit organization.
The Urtikaria Network is a platform where patients and doctors can meet each other in order to fight urticaria together. On the website www.urtikaria.net, people suffering from urticaria or those who are interested in the disease can learn valuable facts about the clinical picture, hear the latest news and get in touch with other people affected or with “urticaria” doctors.
GA²LEN, the Global Allergy and Asthma European Network, has recently launched a programme for the development, interaction and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centres of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard to treat conditions such as urticaria. Here, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA²LEN UCAREs. The main aims of GA²LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities.